ITGAL and immune system disorder: Though bidirectional LFA1 activation is tightly regulated, the bidirectionality of integrin activation can vary not only among different integrins, but also across different cellular and environmental conditions, the context of which provides important clues to find molecular targets for the development of therapeutics for immune diseases and integrin-involved pathological disorders.